Nanochemistry
Where size matters
Pages
(Move to ...)
Home
Donations
Contact Me
▼
Thursday, June 11, 2020
[ASAP] An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy
Nano Letters
DOI: 10.1021/acs.nanolett.0c00953
from Nano Letters: Latest Articles (ACS Publications) https://ift.tt/3dV5EOx
via
IFTTT
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment